Researchers devise age-based eligibility method to measure vaccine effectiveness in data-deficient scenarios Read more
Boehringer Ingelheim enters global licensing agreement to develop and commercialise antibodies from A*STAR for targetted cancer therapies Read more
Enabling CROs, pharma, healthcare and lifesciences industries with disruptive e-signature and smart document solutions Read more